Takao Hoshino Selected Research

Cerebral Arterial Diseases

7/2022

Effects of Pemafibrate in Patients with Stroke and Hypertriglyceridemia: Baseline Cerebral Artery Diseases and 3-Month Laboratory Outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takao Hoshino Research Topics

Disease

6	Stroke (Strokes) 09/2022 - 01/2017
4	Pathologic Constriction (Stenosis) 07/2022 - 11/2014
2	Dyslipidemias (Dyslipidemia) 07/2022 - 01/2017
2	Hypertriglyceridemia 07/2022 - 01/2022
2	Ischemic Stroke 06/2022 - 03/2019
2	Infections 03/2022 - 10/2018
1	Cerebral Arterial Diseases 07/2022
1	Atherosclerosis 07/2022
1	Acute Coronary Syndrome 04/2022
1	Chronic Hepatitis (Chronic Active Hepatitis) 03/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2022
1	Embolic Stroke 03/2019
1	Hemiplegia (Spastic Hemiplegia) 02/2019
1	Hepatitis C 10/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Peripheral Arterial Disease 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Diabetes Mellitus 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Infarction (Infarctions) 01/2017
1	Ischemia 05/2015
1	Hypothermia 05/2015
1	Hypoxia (Hypoxemia) 05/2015
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 05/2015
1	Human Influenza (Influenza) 01/2012

Drug/Important Bio-Agent (IBA)

3	omega-Chloroacetophenone (Mace)IBA 09/2022 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 07/2022 - 01/2022
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 11/2014
1	PPAR alphaIBA 07/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2022
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 07/2022
1	EnzymesIBA 07/2022
1	glecaprevir and pibrentasvirIBA 03/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2019
1	terutrobanIBA 03/2019
1	Acyclovir (Aciclovir)FDA LinkGeneric 02/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2019
1	SteroidsIBA 02/2019
1	Ritonavir (Norvir)FDA Link 10/2018
1	paritaprevirIBA 10/2018
1	ombitasvirIBA 10/2018
1	AnticoagulantsIBA 01/2017
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	Neuroprotective AgentsIBA 05/2015
1	Pyruvic Acid (Pyruvate)IBA 05/2015
1	Amino Acids FDA Link 05/2015
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2015
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 05/2015
1	Choline (Choline Chloride)IBA 05/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 05/2015
1	CarbonIBA 05/2015
1	GangliosidesIBA 01/2012
1	AntibodiesIBA 01/2012

Therapy/Procedure

3	Therapeutics 07/2022 - 02/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2022
1	Renal Dialysis (Hemodialysis) 09/2022
1	Stents 06/2022
1	Aftercare (After-Treatment) 03/2022
1	Secondary Prevention 03/2019
1	Induced Hypothermia 05/2015